Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 55,357 | 46,245 | 53,384 | 98,169 | 52,557 |
| Cost of Goods | 11,896 | 10,279 | 11,969 | 29,557 | 10,940 |
| Gross Profit | 43,461 | 35,966 | 41,415 | 68,612 | 41,617 |
| Operating Expenses | 37,626 | 45,199 | 59,017 | 49,023 | 53,706 |
| Operating Income | 6,731 | -8,954 | -16,633 | 20,146 | -11,149 |
| Interest Expense | 2,718 | 3,121 | 3,518 | 3,450 | 3,567 |
| Other Income | 322 | -32,560 | 15,083 | -130 | -71 |
| Pre-tax Income | 4,335 | -44,635 | -5,068 | 16,566 | -14,787 |
| Income Tax | 211 | 37 | 38 | 38 | N/A |
| Net Income Continuous | 4,124 | -44,672 | -5,106 | 16,528 | -14,994 |
| Net Income | $4,124 | $-44,672 | $-5,106 | $16,528 | $-14,994 |
| EPS Basic Total Ops | 0.09 | -1.09 | -0.13 | 0.41 | -0.39 |
| EPS Basic Continuous Ops | 0.09 | -1.09 | -0.13 | 0.41 | -0.38 |
| EPS Diluted Total Ops | 0.10 | -1.09 | -0.13 | 0.40 | -0.38 |
| EPS Diluted Continuous Ops | 0.10 | -1.09 | -0.13 | 0.40 | -0.38 |
| EBITDA(a) | $9,709 | $-6,513 | $-13,698 | $23,097 | $-8,201 |